Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

32.48
Delayed Data
As of Feb 08
 -0.29 / -0.88%
Today’s Change
29.20
Today|||52-Week Range
45.43
+0.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues231.8M226.5M213.4M219.7M
 
 
 
 
 
Cost of Goods Sold97.9M96.0M88.6M91.7M
 
 
 
 
 
Depreciation And Amortization22.3M22.2M22.3M22.7M
 
 
 
 
 
 
Operating ExpensesGross Income111.7M108.4M102.5M105.3M
 
 
 
 
 
General Expenses80.5M81.3M84.1M79.5M
 
 
 
 
 
Research And Development10.6M17.2M11.3M11.6M
 
 
 
 
 
Total Operating Expenses200.7M199.4M195.0M193.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income31.2M27.1M18.4M25.8M
 
 
 
 
 
Extraordinary Credit----637.0K160.0K
 
 
 
Extraordinary Charge-12.9M-15.5M-14.8M-6.7M
 
 
 
 
 
Interest Expense On Debt2.3M1.9M2.6M2.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income16.0M9.7M1.6M16.6M
 
 
 
 
 
Income Taxes-36.0K-12.6M-1.9M-3.7M
 
 
 
 
 
Net Income16.0M-2.9M-267.0K12.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.4M51.6M51.4M50.7M
 
 
 
 
 
Shares To Calculate EPS Diluted52.0M51.6M51.4M51.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.31-$0.06-$0.01$0.25
 
 
 
 
 
EPS Diluted$0.31-$0.06-$0.01$0.25